Annual EBITDA
$718.75M$522.15M+265.59%
Summary
- Current Value
- As of today, EXEL annual EBITDA is $718.75M, up +265.59% on
- Historical Performance
- EXEL annual EBITDA is up +139.35% over the past 3 years, and up +88.83% over the past 5 years
- All-Time High Comparison
- EXEL annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual EBITDA is +265.59% above its 3-year low of $196.60M reached on
- Sector Comparison
- EXEL annual EBITDA is higher than 92.92% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $718.75M | +265.6% | +139.3% | +88.8% | +757.5% | |
| Quarterly EBITDA | $263.78M | +35.1% | +181.3% | +776.3% | +10000.0% | |
| TTM EBITDA | $850.00M | +33.7% | +115.2% | +383.8% | +1361.5% | |
| Price | $41.36 | +25.6% | +137.8% | +86.2% | +379.8% | |
| PE Ratio | 17.41 | -6.3% | -43.8% | -72.6% | – | |
| Annual Revenue | $2.17B | +18.5% | +51.1% | +124.1% | +1329.0% | |
| Annual EPS | $1.76 | +172.3% | +145.6% | +72.7% | +239.7% | |
| $689.95M | +303.8% | +140.7% | +86.7% | +666.0% | ||
| Annual Net Income | $521.27M | +150.9% | +125.6% | +62.4% | +473.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $718.75M | at high | |
| 5Y | $718.75M | at high | |
| All | $718.75M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $196.60M | +265.6% | |
| 5Y | $124.03M | N/A | +479.5% |
| All | -$214.97M | +434.4% |
EBITDA History
FAQ
What is the current annual EBITDA of EXEL?
As of today, EXEL annual EBITDA is $718.75M
What is 1-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +265.59% year-over-year
What is 3-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +139.35% over the past 3 years
How far is EXEL annual EBITDA from its all-time high?
EXEL annual EBITDA is currently at its all-time high
How does EXEL annual EBITDA rank versus sector peers?
EXEL annual EBITDA is higher than 92.92% of companies in Healthcare sector
When is EXEL next annual earnings release?
The next annual earnings release for EXEL is on
Quarterly EBITDA
$263.78M$42.86M+19.40%
Summary
- Current Value
- As of today, EXEL quarterly EBITDA is $263.78M, up +19.40% on
- Historical Performance
- EXEL quarterly EBITDA is up +35.07% year-over-year, and up +181.32% over the past 3 years
- All-Time High Comparison
- EXEL quarterly EBITDA is currently -7.01% below its historical high of $283.68M set on
- 3-Year Low Comparison
- EXEL quarterly EBITDA is +726.08% above its 3-year low of -$42.13M reached on an earlier date
- Sector Comparison
- EXEL quarterly EBITDA is higher than 93.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $263.78M | +19.4% | +35.1% | +181.3% | +776.3% | |
| Annual EBITDA | $718.75M | – | +265.6% | +139.3% | +88.8% | |
| TTM EBITDA | $850.00M | +8.8% | +33.7% | +115.2% | +383.8% | |
| Price | $41.36 | +6.2% | +25.6% | +137.8% | +86.2% | |
| PE Ratio | 17.41 | +6.2% | -6.3% | -43.8% | -72.6% | |
| Quarterly Revenue | $597.76M | +5.2% | +10.8% | +45.2% | +158.7% | |
| Quarterly EPS | $0.70 | +6.9% | +71.7% | +208.6% | +770.9% | |
| $256.36M | +20.0% | +36.5% | +210.3% | +702.1% | ||
| Quarterly Net Income | $193.58M | +4.7% | +64.1% | +164.4% | +704.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $263.78M | at high | |
| 3Y | $283.68M | -7.0% | |
| 5Y | $283.68M | -7.0% | |
| All | $283.68M | -7.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $171.10M | N/A | +54.2% |
| 3Y | -$42.13M | N/A | +726.1% |
| 5Y | -$42.13M | +726.1% | |
| All | -$64.44M | +509.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of EXEL?
As of today, EXEL quarterly EBITDA is $263.78M
What is EXEL quarterly EBITDA most recent change?
EXEL quarterly EBITDA was up +19.40% on September 1, 2025
What is 1-year change in EXEL quarterly EBITDA?
EXEL quarterly EBITDA is up +35.07% year-over-year
How far is EXEL quarterly EBITDA from its all-time high?
EXEL quarterly EBITDA is currently -7.01% below its historical high of $283.68M set on June 28, 2024
How does EXEL quarterly EBITDA rank versus sector peers?
EXEL quarterly EBITDA is higher than 93.36% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM EBITDA
$850.00M$68.48M+8.76%
Summary
- Current Value
- As of today, EXEL TTM EBITDA is $850.00M, up +8.76% on
- Historical Performance
- EXEL TTM EBITDA is up +33.66% year-over-year, and up +115.19% over the past 3 years
- All-Time High Comparison
- EXEL TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL TTM EBITDA is +960.70% above its 3-year low of $80.14M reached on
- Sector Comparison
- EXEL TTM EBITDA is higher than 92.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $850.00M | +8.8% | +33.7% | +115.2% | +383.8% | |
| Annual EBITDA | $718.75M | – | +265.6% | +139.3% | +88.8% | |
| Quarterly EBITDA | $263.78M | +19.4% | +35.1% | +181.3% | +776.3% | |
| Price | $41.36 | +6.2% | +25.6% | +137.8% | +86.2% | |
| PE Ratio | 17.41 | +6.2% | -6.3% | -43.8% | -72.6% | |
| TTM Revenue | $2.29B | +2.6% | +9.9% | +39.7% | +138.9% | |
| TTM EPS | $2.38 | +13.9% | +51.4% | +150.2% | +396.4% | |
| $820.25M | +9.1% | +34.9% | +124.0% | +403.0% | ||
| TTM Net Income | $677.90M | +12.6% | +45.2% | +120.4% | +345.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $850.00M | at high | |
| 3Y | $850.00M | at high | |
| 5Y | $850.00M | at high | |
| All | $850.00M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $718.75M | N/A | +18.3% |
| 3Y | $80.14M | +960.7% | |
| 5Y | $67.71M | +1155.3% | |
| All | -$238.61M | +456.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of EXEL?
As of today, EXEL TTM EBITDA is $850.00M
What is EXEL TTM EBITDA most recent change?
EXEL TTM EBITDA was up +8.76% on September 1, 2025
What is 1-year change in EXEL TTM EBITDA?
EXEL TTM EBITDA is up +33.66% year-over-year
How far is EXEL TTM EBITDA from its all-time high?
EXEL TTM EBITDA is currently at its all-time high
How does EXEL TTM EBITDA rank versus sector peers?
EXEL TTM EBITDA is higher than 92.54% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- EXEL Official Website www.exelixis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/939767/000093976725000019/0000939767-25-000019-index.htm
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel